000 01513 a2200409 4500
005 20250516103151.0
264 0 _c20121025
008 201210s 0 0 eng d
022 _a1749-6632
024 7 _a10.1111/j.1749-6632.2012.06524.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKraus, Jürgen
245 0 0 _aExpression and functions of μ-opioid receptors and cannabinoid receptors type 1 in T lymphocytes.
_h[electronic resource]
260 _bAnnals of the New York Academy of Sciences
_cJul 2012
300 _a1-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnalgesics, Opioid
_ximmunology
650 0 4 _aAnimals
650 0 4 _aAzacitidine
_xanalogs & derivatives
650 0 4 _aCannabinoids
_ximmunology
650 0 4 _aCyclic AMP
_ximmunology
650 0 4 _aDecitabine
650 0 4 _aHumans
650 0 4 _aHydroxamic Acids
_xpharmacology
650 0 4 _aInterleukin-2
_xantagonists & inhibitors
650 0 4 _aInterleukin-4
_ximmunology
650 0 4 _aJurkat Cells
650 0 4 _aLymphocyte Activation
_xdrug effects
650 0 4 _aMice
650 0 4 _aNeuroimmunomodulation
650 0 4 _aReceptor, Cannabinoid, CB1
_ximmunology
650 0 4 _aReceptors, Opioid, mu
_ximmunology
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aT-Lymphocytes
_xdrug effects
773 0 _tAnnals of the New York Academy of Sciences
_gvol. 1261
_gp. 1-6
856 4 0 _uhttps://doi.org/10.1111/j.1749-6632.2012.06524.x
_zAvailable from publisher's website
999 _c21967234
_d21967234